Epirubicin and cardiac failure Patient Reports February 12, 2012



Epirubicin Side Effects Report #5583284-6
Epirubicin side effect was reported by a Consumer or non-health professional from JAPAN on Dec 26, 2007. Female patient, 72 years of age, was diagnosed with malignant fibrous histiocytoma and was treated with Epirubicin. After drug was administered, patient experienced the following side effects: altered state of consciousness, cardiac failure, febrile neutropenia, hyponatraemia, respiratory failure, sepsis What is  sepsis. Epirubicin dosage: DAILY DOSE:40MG-FREQ:ON DAYS 2 AND 4. During the same period patient was treated with IFOSFAMIDE, LENOGRASTIM. Patient recovered.

Epirubicin Side Effects Report #5921037-7
Epirubicin side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Oct 06, 2008. Female patient, 57 years of age, was diagnosed with breast cancer recurrent and was treated with Epirubicin. After drug was administered, patient experienced the following side effects: cardiac failure, ejection fraction decreased. Epirubicin dosage: unknown. During the same period patient was treated with VINORELBINE, CAPECITABINE, TRASTUZUMAB, GOSERELIN, ANASTROZOLE. Patient was hospitalized. Patient recovered.

Epirubicin Side Effects Report #4850729-6
Epirubicin side effect was reported by a Physician from JAPAN on Nov 25, 2005. Female patient, 53 years of age, was diagnosed with breast cancer recurrent and was treated with Epirubicin. After drug was administered, patient experienced the following side effects: cardiac failure, lymphangiosis carcinomatosa, neutropenia, respiratory failure, white blood cell count decreased. Epirubicin dosage: 75M/MG2 INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, HYSRON. Patient died on 11/08/2005.

Epirubicin Side Effects Report #5225551-1
Epirubicin side effect was reported by a Physician from JAPAN on Jan 19, 2007. Female patient, 65 years of age, was diagnosed with breast cancer metastatic, metastases to bone and was treated with Epirubicin. After drug was administered, patient experienced the following side effects: cardiac failure, hepatic function abnormal. Epirubicin dosage: DAILY DOSE:60MG/M*2. During the same period patient was treated with FLUOROURACIL, ENDOXAN, ZOMETA. Patient was hospitalized. Patient died on 01/22/2007.


Epirubicin Side Effects Report #5243247-7
Epirubicin side effect was reported by a Physician from JAPAN on Feb 09, 2007. Female patient, 65 years of age, was diagnosed with breast cancer metastatic, metastases to bone and was treated with Epirubicin. After drug was administered, patient experienced the following side effects: cardiac failure, liver disorder. Epirubicin dosage: DAILY DOSE:60MG/M*2. During the same period patient was treated with FLUOROURACIL, ENDOXAN, ZOMETA. Patient was hospitalized. Patient died on 01/22/2007.

Epirubicin Side Effects Report #5909442-6
Epirubicin side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Sept 24, 2008. Female patient, 57 years of age, was diagnosed with breast cancer metastatic and was treated with Epirubicin. After drug was administered, patient experienced the following side effects: breast cancer metastatic, cardiac failure, cerebellar ataxia, disease progression, ejection fraction decreased, lymphoedema. Epirubicin dosage: unknown. During the same period patient was treated with CAPECITABINE, TRASTUZUMAB, VINORELBINE. Patient was hospitalized. Patient recovered.

Epirubicin Side Effects Report #5251844-8
Epirubicin side effect was reported by a Physician from JAPAN on Feb 16, 2007. Female patient was diagnosed with breast cancer metastatic, metastases to bone and was treated with Epirubicin. After drug was administered, patient experienced the following side effects: cardiac failure, liver disorder. Epirubicin dosage: DAILY DOSE:60MG/M*2. During the same period patient was treated with FLUOROURACIL, ENDOXAN, ZOMETA, LANIRAPID, TAKEPRON, GASCON, MAGNESIUM OXIDE. Patient was hospitalized. Patient died on 01/22/2007.

Epirubicin Side Effects Report #5258103-8
Epirubicin side effect was reported by a Physician from JAPAN on Feb 23, 2007. Female patient was diagnosed with breast cancer metastatic, metastases to bone and was treated with Epirubicin. After drug was administered, patient experienced the following side effects: cardiac failure, hepatic failure. Epirubicin dosage: DAILY DOSE:60MG/M*2. During the same period patient was treated with FLUOROURACIL, ENDOXAN, ZOMETA, LANIRAPID, TAKEPRON, GASCON, MAGNESIUM OXIDE. Patient was hospitalized. Patient died on 01/22/2007.

Epirubicin Side Effects Report #5298325-3
Epirubicin side effect was reported by a Physician from JAPAN on Apr 04, 2007. Female patient, weighting 134.5 lb, was diagnosed with breast cancer metastatic, metastases to bone and was treated with Epirubicin. After drug was administered, patient experienced the following side effects: cardiac failure, hepatic failure, pleural effusion. Epirubicin dosage: DAILY DOSE:90MG. During the same period patient was treated with FLUOROURACIL, ENDOXAN, ZOMETA, TAKEPRON, GASCON, MAGNESIUM OXIDE, LENDORMIN, MEVALOTIN. Patient was hospitalized. Patient died on 01/22/2007.


Epirubicin Side Effects Report #5330430-5
Epirubicin side effect was reported by a Consumer or non-health professional from JAPAN on May 09, 2007. Female patient, 66 years of age, was diagnosed with breast cancer What is  breast cancer and was treated with Epirubicin. After drug was administered, patient experienced the following side effects: cardiac failure. Epirubicin dosage: DAILY DOSE:30MG/M2-FREQ:CYCLIC. During the same period patient was treated with TRASTUZUMAB, CYCLOPHOSPHAMIDE, FLUOROURACIL, DOCETAXEL. Patient was hospitalized. Patient recovered.

Epirubicin Side Effects Report #5335227-8
Epirubicin side effect was reported by a Consumer or non-health professional from JAPAN on May 16, 2007. Female patient, 66 years of age, was diagnosed with breast cancer What is  breast cancer and was treated with Epirubicin. After drug was administered, patient experienced the following side effects: cardiac failure. Epirubicin dosage: DAILY DOSE:30MG/M2-FREQ:CYCLIC. During the same period patient was treated with TRASTUZUMAB, CYCLOPHOSPHAMIDE, FLUOROURACIL, DOCETAXEL. Patient was hospitalized. Patient recovered.

Epirubicin Side Effects Report #4692288-7
Epirubicin side effect was reported by a Consumer or non-health professional from on May 31, 2005. Female patient was diagnosed with breast cancer What is  breast cancer and was treated with Epirubicin. After drug was administered, patient experienced the following side effects: cardiac failure. Epirubicin dosage: 90 MG/M2 PER -CYCLE; IV. During the same period patient was treated with PACLITAXEL. Patient recovered.

Epirubicin Side Effects Report #4693618-2
Epirubicin side effect was reported by a Consumer or non-health professional from on May 31, 2005. Female patient was diagnosed with breast cancer What is  breast cancer and was treated with Epirubicin. After drug was administered, patient experienced the following side effects: cardiac failure, ejection fraction decreased. Epirubicin dosage: 100 MG/M2 PER CYCLE. During the same period patient was treated with PACLITAXEL. Patient recovered.

Epirubicin Side Effects Report #4693636-4
Epirubicin side effect was reported by a Consumer or non-health professional from on May 31, 2005. Female patient was diagnosed with breast cancer What is  breast cancer and was treated with Epirubicin. After drug was administered, patient experienced the following side effects: cardiac failure, procedural complication. Epirubicin dosage: 90 MG/M2 PER_CYCLE IV. During the same period patient was treated with PACLITAXEL. Patient recovered.


Epirubicin Side Effects Report #4693637-6
Epirubicin side effect was reported by a Consumer or non-health professional from on May 31, 2005. Female patient was diagnosed with breast cancer What is  breast cancer and was treated with Epirubicin. After drug was administered, patient experienced the following side effects: cardiac failure, ejection fraction decreased. Epirubicin dosage: 90 MG/M2 PER_CYCLE IV. During the same period patient was treated with PACLITAXEL. Patient died.

Epirubicin Side Effects Report #4693639-X
Epirubicin side effect was reported by a Consumer or non-health professional from on May 31, 2005. Female patient was diagnosed with breast cancer What is  breast cancer and was treated with Epirubicin. After drug was administered, patient experienced the following side effects: cardiac failure, cardiomyopathy What is  cardiomyopathy. Epirubicin dosage: 90 MG/M2 PER_CYCLE IV. During the same period patient was treated with PACLITAXEL, MITOXANTRONE. Patient died.

Epirubicin Side Effects Report #4693640-6
Epirubicin side effect was reported by a Consumer or non-health professional from on May 31, 2005. Female patient was diagnosed with breast cancer What is  breast cancer and was treated with Epirubicin. After drug was administered, patient experienced the following side effects: cardiac failure, ejection fraction decreased. Epirubicin dosage: 90 MG/M2 PER_CYCLE IV. During the same period patient was treated with PACLITAXEL. Patient recovered.

Epirubicin Side Effects Report #4693653-4
Epirubicin side effect was reported by a Consumer or non-health professional from on May 31, 2005. Female patient was diagnosed with breast cancer What is  breast cancer and was treated with Epirubicin. After drug was administered, patient experienced the following side effects: cardiac failure, ejection fraction decreased. Epirubicin dosage: 90 MG/M2 PER_CYCLE IV. During the same period patient was treated with PACLITAXEL. Patient recovered.
SideEffects101.com does not provide medical advice, diagnosis or treatment. The material on this site is for informational purposes only, and is not a substitute for medical advice, diagnosis or treatment provided by a qualified health care provider. Thank you for visiting SideEffects101.com and reading about

side effects of Epirubicin